equitam
momenta farmacÊutica ltda. - ginkgo biloba l. - vasodilatadores
hemofil
shire farmacÊutica brasil ltda. - fator viii de coagulaÇÃo - sangue total ou plasma
hemofil
baxalta brasil biociÊncia ltda - sangue total ou plasma
zomig/zomig od
astrazeneca do brasil ltda - analgesicos contra enxaqueca
advil
wyeth indÚstria farmacÊutica ltda - ibuprofeno - analgesicos nao narcoticos
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - artrite, reumatóide - imunossupressores - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
hemofil
takeda pharma ltda. - fator viii de coagulaÇÃo - sangue total ou plasma
willentine
mawdsleys pharmaceuticals do brasil ltda - dicloridrato de trientina - moduladores do metabolismo e da digestao
ibuprofeno
althaia s.a indústria farmacêutica - ibuprofeno - antinflamatorios antireumaticos
ibuprofeno
laboratÓrio teuto brasileiro s/a - ibuprofeno - antinflamatorios antireumaticos